Tao Wang

3.3k citations
221 papers · 1.8k indexed · 2 hit papers · h-index 21
Topics
Acute Lymphoblastic Leukemia research (14 papers)Liver Disease Diagnosis and Treatment (10 papers)CAR-T cell therapy research (8 papers)

In The Last Decade

Tao Wang

174 papers receiving 1.8k citations

Hit Papers

Infection and co-infection patterns of community-acquired...2023202620242025202320254080120

Peers

Tao Wang
Comparison fields: 5 of 168
  • Molecular Biology 441
  • Epidemiology 247
  • Oncology 238
  • Public Health, Environmental and Occupational Health 218
  • Pulmonary and Respiratory Medicine 150
Replace Dhruv Kumar with:
Dhruv Kumar India
Yi Wang China
Dan Liu China
Xu Chen China
Dandan Li China
Yuguo Chen China
Zhi Wang China
Sheng Yang China
Wei Yang China
Mengyuan Li China
Tao Wang relative to Dhruv Kumar India Dhruv Kumar's profile →
Citations per field
00.5×1.5×2.3×
Dhruv Kumar · 1×
Citations per year

Countries citing papers authored by Tao Wang

Since Specialization
Citations

This map shows the geographic impact of Tao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Wang more than expected).

Fields of papers citing papers by Tao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Wang. The network helps show where Tao Wang may publish in the future.

Co-authorship network of co-authors of Tao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Wang. A scholar is included among the top collaborators of Tao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Wang. Tao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 12
2 0
3 2
4 4
5 1
6 5
7 4
8 0
9 1
10 0
11 0
12 0
13 0
14 3
15 1
16 2
17 18
18 12
19 16
20 29

About Tao Wang

Tao Wang is a scholar working on General Energy, Public Health, Environmental and Occupational Health and Pharmacology, having authored 221 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (14 papers), Liver Disease Diagnosis and Treatment (10 papers) and CAR-T cell therapy research (8 papers). The work is most often cited by research in Complementary and alternative medicine (124 citations), Pharmacology (92 citations) and Pharmaceutical Science (56 citations). Tao Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Pasquale Aragona, Peter A. Simmons, Hongpeng Wang, Zhongqiu Liu, Lan Tang, Aiqing Li, Hongbo Zhou, Ming Hu, Wei Liu and Zhen Yang. Their work appears in journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026